Question follow-through · 111042

Dementia: Research

To ask the Secretary of State for Health and Social Care, how much funding was allocated to dementia research by (a) the National Institute for Health and Care Research and (b) UK Research and Innovation in each of the last five years.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
4 Feb 2026
Target answer date
10 Feb 2026
Answer
10 Feb 2026 · 6 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 4 Feb 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, how much funding was allocated to dementia research by (a) the National Institute for Health and Care Research and (b) UK Research and Innovation in each of the last five years.

  2. 10 Feb 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 10 Feb 2026

    Answer published

    Government responsibility for delivering dementia research is shared between the Department of Health and Social Care, with research delivered via the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and T...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hormone Replacement Therapy

10 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to to the answers of 5 and 17 October 2025 to Questions 77387 and 86538, what progress he has made on ensuring a reliable supply of testosterone and oestrogen HRT implants.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Givinostat

10 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 19th January to question 105612, to ask what role the Department for Health and Social Care will have in drug price negotiations following the abolishment of NHS England.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Alzheimer's Disease: Carers

11 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether his Department plans to ensure that the (a) psychological, (b) social and (b) financial impacts of caring for someone with Alzheimer’s disease are accounted for as part of National Institut

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services: Foreign Nationals

11 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that overseas visitor charging regulations are applied uniformly across NHS trusts.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Spinal Muscular Atrophy: Babies

2 Mar 2026 · To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure that screening as part of the in-service evaluation of newborn screening of spinal muscular atrophy is commenced.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Spinal Muscular Atrophy: Babies

2 Mar 2026 · To ask the Secretary of State for Health and Social Care, what steps are being taken to mitigate disparities in outcomes associated with partial geographical coverage of the in-service evaluation of newborn screening for spinal muscular atrophy.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Spinal Muscular Atrophy: Babies

2 Mar 2026 · To ask the Secretary of State for Health and Social Care, what assessment has been made of the potential impact that delays in access to newborn screening for spinal muscular atrophy will have on those not part of the upcoming in-service evaluation of scr

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medical Treatments

2 Mar 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the answer on 20 November 2025 to question 90583 on medical treatments, (a) what progress has been made on the establishment of the MHRA Early Access Service and (b) when they expect to

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medical Treatments

2 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to prioritise the assessment of breakthrough implantable devices in the MHRA Early Access Service.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Maternity Services

4 Mar 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to identify and tackle systemic causes of avoidable harm in maternity and neonatal services.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Maternity Services: Reviews

4 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether his Department plans to publish a response when the final part of the Amos Review has been delivered; and what preparatory work his Department has undertaken to respond to the anticipated r

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Maternity Services: Reviews

4 Mar 2026 · To ask the Secretary of State for Health and Social Care, what consideration the Department has given to Baroness Amos' interim report’s findings regarding the limited progress on recommendations from previous maternity investigations, and how this will i